0001193805-22-001729.txt : 20221215 0001193805-22-001729.hdr.sgml : 20221215 20221215160628 ACCESSION NUMBER: 0001193805-22-001729 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221213 FILED AS OF DATE: 20221215 DATE AS OF CHANGE: 20221215 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Neermann Joerg CENTRAL INDEX KEY: 0001773900 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36201 FILM NUMBER: 221464848 MAIL ADDRESS: STREET 1: IMMUNIC AG STREET 2: AM KLOPFERSPITZ 19 CITY: MARTINSRIED STATE: 2M ZIP: 82152 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IMMUNIC, INC. CENTRAL INDEX KEY: 0001280776 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 562358443 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1200 AVENUE OF THE AMERICAS STREET 2: SUITE 200 CITY: NEW YORK STATE: X1 ZIP: 10036 BUSINESS PHONE: (332) 255-9818 MAIL ADDRESS: STREET 1: 1200 AVENUE OF THE AMERICAS STREET 2: SUITE 200 CITY: NEW YORK STATE: X1 ZIP: 10036 FORMER COMPANY: FORMER CONFORMED NAME: VITAL THERAPIES INC DATE OF NAME CHANGE: 20040219 4 1 e618126_4-jorg.xml X0306 4 2022-12-13 0 0001280776 IMMUNIC, INC. IMUX 0001773900 Neermann Joerg 1200 AVENUE OF THE AMERICAS, SUITE 200 NEW YORK NY 10036 1 0 0 0 Common Stock 2022-12-13 4 P 0 35000 1.246 A 53000 D Common Stock 2022-12-14 4 P 0 47000 1.256 A 100000 D The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions at prices ranging from $1.23 to $1.28 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought by him at each separate price on December 13, 2022. The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions at prices ranging from $1.22 to $1.28 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought by him at each separate price on December 14, 2022. /s/ Joerg Neermann 2022-12-15